BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3164639)

  • 1. Induction to erythroid differentiation of K562 cells by 1-beta-D-arabinofuranosylcytosine is inhibited by iron chelators: reversion by treatment with hemin.
    Feriotto G; Nastruzzi C; Barbieri R; Gambari R
    Blut; 1988 Jul; 57(1):25-30. PubMed ID: 3164639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
    Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemin uptake by erythroleukemic cells treated with iron chelators: effects on the induced expression of differentiated functions.
    Feriotto G; Nastruzzi C; Traniello F; Barbieri R; Gambari R
    Boll Soc Ital Biol Sper; 1987 Oct; 63(10):869-73. PubMed ID: 3482157
    [No Abstract]   [Full Text] [Related]  

  • 4. ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL.
    Clausen PA; Athanasiou M; Chen Z; Dunn KJ; Zhang Q; Lautenberger JA; Mavrothalassitis G; Blair DG
    Leukemia; 1997 Aug; 11(8):1224-33. PubMed ID: 9264374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin induction by Ara-C in human erythroleukemic cells (K562) is cell-cycle dependent.
    Wanda PE; Walker MM
    Leuk Res; 1989; 13(8):683-8. PubMed ID: 2796376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
    Toffoli G; Viel A; Bevilacqua C; Maestro R; Tumiotto L; Boiocchi M
    Leuk Res; 1989; 13(4):279-87. PubMed ID: 2654492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desferrioxamine-mediated inhibition of heme and hemoglobin synthesis in murine erythroleukemia cells: expression of globin genes and commitment to erythroid differentiation.
    Gambari R
    Cell Biol Int Rep; 1983 Oct; 7(10):785-95. PubMed ID: 6580089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
    Cancer Res; 1991 Sep; 51(17):4535-8. PubMed ID: 1873797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globin synthesis and erythroid differentiation in a Friend cell variant deficient in heme synthesis.
    Rutherford TR; Harrison PR
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5660-4. PubMed ID: 293668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha.
    Li XF; Anderson J; Hutzler D; Roodman GD
    Exp Hematol; 1989 Dec; 17(11):1059-62. PubMed ID: 2555212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation in erythroleukemic K562 cells by gamma-irradiation.
    Schwenke K; Peterson HP; Wangenheim KH; Feinendegen LE
    Leuk Res; 1995 Dec; 19(12):955-61. PubMed ID: 8632665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hemoglobin synthesis in murine erythroleukemic cells: hemin effects.
    Zucker RM; Umlas ME; Decal DL; Whittington KB
    Cell Biochem Funct; 1987 Jan; 5(1):27-35. PubMed ID: 3469035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hemoglobin accumulation by monoclonal antibodies to the human transferrin receptor is reversed by hemin.
    Viola L; Biagini R; Barbieri R; Gambari R
    Exp Hematol; 1987 Dec; 15(11):1145-52. PubMed ID: 2445597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in chemosensitivity of K 562 leukemia cells after induction of erythroid differentiation by hemin.
    Toffoli G; Lorico A; Boiocchi M
    Tumori; 1988 Feb; 74(1):11-7. PubMed ID: 3162623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of heme on intracellular iron pools during differentiation of Friend erythroleukemia cells.
    Hradilek A; Borová J; Fuchs O; Neuwirt J
    Biochim Biophys Acta; 1981 Dec; 678(3):373-80. PubMed ID: 6947826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol lipid metabolism accompanies erythroid differentiation of K562 human leukemic cells.
    Klette KL; Wanda PE
    Leuk Res; 1991; 15(6):453-6. PubMed ID: 1650410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of liposome-entrapped desferrioxamine on proliferation and erythroid differentiation of murine erythroleukemic Friend cells.
    Nastruzzi C; Walde P; Menegatti E; Gambari R
    Biochim Biophys Acta; 1989 Sep; 1013(1):36-41. PubMed ID: 2790036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of hemoglobin synthesis, iron metabolism, and maturation of Friend leukemic cells by 5-amino levulinic acid and hemin.
    Malik Z; Halbrecht I; Djaldetti M
    Differentiation; 1979; 13(2):71-9. PubMed ID: 288721
    [No Abstract]   [Full Text] [Related]  

  • 20. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
    Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
    Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.